Is this your firm? Get featured or correct your listing →
Strategy
Geographies
Greenwich, United States
Portfolio
1 totalCo-Investors
7Similar Firms
overlapping sector, stage or regionValue Add Research
Latest Pulse
- Oct 16, 2026City Therapeutics Prices Upsized $200M IPO At $18City Therapeutics priced its upsized IPO at $18 a share for about $200 million in gross proceeds, above the terms Pulse covered in early October, with Nasdaq trading under ticker CTY starting October 16.→
- Oct 11, 2026TriGemX Bio Raises $94M For Migraine DrugTriGemX Bio, formerly Kallyope, raised $94 million co-led by The Column Group, TCGX and Viking Global to push its migraine drug elismetrep through Phase 3.→
Viking Global Investors FAQ
What companies has Viking Global Investors invested in?
Viking Global Investors' portfolio includes Triveni Bio.
Who does Viking Global Investors co-invest with most?
In the rounds Value Add tracks, Viking Global Investors most often invests alongside Ascenta Capital (1 shared deal), Atlas Venture (1 shared deal), Cormorant Asset Management (1 shared deal), Deep Track Capital (1 shared deal), Fidelity Investments (1 shared deal).